These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21885976)

  • 21. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N; Ehlers S; Hölscher C
    Immunol Lett; 2008 Feb; 116(1):15-23. PubMed ID: 18191460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological basis of systemic sclerosis.
    Zuber JP; Spertini F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity and inflammation in systemic sclerosis.
    Lafyatis R; York M
    Curr Opin Rheumatol; 2009 Nov; 21(6):617-22. PubMed ID: 19633559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor recognition of Toxoplasma gondii.
    Yarovinsky F; Sher A
    Int J Parasitol; 2006 Mar; 36(3):255-9. PubMed ID: 16476433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
    Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
    J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammasome activation: from inflammatory disease to infection.
    Dunne A
    Biochem Soc Trans; 2011 Apr; 39(2):669-73. PubMed ID: 21428959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primer: inflammasomes and interleukin 1beta in inflammatory disorders.
    Church LD; Cook GP; McDermott MF
    Nat Clin Pract Rheumatol; 2008 Jan; 4(1):34-42. PubMed ID: 18172447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?
    Candia L; Marquez J; Hernandez C; Zea AH; Espinoza LR
    J Rheumatol; 2007 Feb; 34(2):374-9. PubMed ID: 17183618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.
    Liu X; Zhan Z; Xu L; Ma F; Li D; Guo Z; Li N; Cao X
    J Immunol; 2010 Dec; 185(12):7244-51. PubMed ID: 21068402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
    Ahonen CL; Doxsee CL; McGurran SM; Riter TR; Wade WF; Barth RJ; Vasilakos JP; Noelle RJ; Kedl RM
    J Exp Med; 2004 Mar; 199(6):775-84. PubMed ID: 15007094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
    Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
    Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor function and signaling.
    Kaisho T; Akira S
    J Allergy Clin Immunol; 2006 May; 117(5):979-87; quiz 988. PubMed ID: 16675322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
    Sakkas LI; Chikanza IC; Platsoucas CD
    Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
    Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.